Genomic biomarkers are measurable genetic indicators that help reveal an individual’s risk of disease, response to treatment, or likelihood of experiencing adverse drug reactions. These biomarkers include gene mutations, copy number variations, expression profiles, and epigenetic signatures that provide valuable insights into underlying biological mechanisms. By identifying specific genomic patterns, clinicians can diagnose diseases earlier, classify subtypes more accurately, and tailor therapies to match a patient’s molecular profile. Genomic biomarkers have become essential tools in oncology, cardiovascular medicine, neurology, and metabolic disorders, enabling precise prediction of therapeutic outcomes. Their role extends to monitoring disease progression, evaluating treatment effectiveness, and guiding personalized prevention strategies.
| Stage 1 |
Initial Quality & Plagiarism Check The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns. |
| Stage 2 |
Editorial Assessment & Peer Review Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy. |
| Stage 3 |
Revision & Editorial Decision Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed. |
| Stage 4 |
Production & Publication Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication. |
| English | Publication Language |
| Single-Blind | Peer-Review Model |
| 17% | Acceptance Rate |
| <18% | Similarity Screening Guideline |
| Open Access | Access Model |
All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.